About: Beth Karlan     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:Person, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FBeth_Karlan

Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine.

AttributesValues
rdf:type
rdfs:label
  • Beth Karlan (en)
rdfs:comment
  • Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine. (en)
foaf:name
  • Beth Karlan (en)
name
  • Beth Karlan (en)
birth place
  • New York City, New York, US (en)
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
sameAs
workplaces
dbp:wikiPageUsesTemplate
education
  • BA, Biochemical Sciences, 1978, Radcliffe College (en)
  • MD, 1982, Harvard Medical School and Harvard-M.I.T. Program in Health Sciences and Technology (en)
image size
main interests
  • Gynecologic Cancers and Inherited Cancer Risk (en)
spouse
  • Scott R. Karlan (en)
has abstract
  • Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine. Karlan is best known for her clinical efforts in identifying, treating, and preventing ovarian cancer, and her research focuses on inherited cancer risk, specifically cancers related to BRCA1/2 mutations. Her research has identified subtype-specific biomarkers for early detection, prognostication, and personalized therapies in gynecologic malignancies. (en)
prov:wasDerivedFrom
page length (characters) of wiki page
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (61 GB total memory, 51 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software